BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for...
DUBLIN, March 25, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform...
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025...
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of...
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025 ORX750 Phase...
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of ExperienceEXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) --...
Innovative platform eliminates endless scrolling and care dead-ends with smart triage, personalized care matching, and real-time provider availability DALLAS, March...
DELRAY BEACH, Fla., March 20, 2025 /PRNewswire/ -- The global US Remote Patient Monitoring Market, valued at US$14.15 billion in...
Positive Interim Blinded Data Supports Advancement Toward Potential Pivotal Phase 3 StudyPHOENIX, March 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology...
Monopoint system enables rapid access to the venous system Research to be presented at SNIS Cerebral Venous and CSF Disorders...
New Novartis Phase III data demonstrate meaningful efficacy and safety results of intrathecal onasemnogene abeparvovec in broad patient population with...
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year...
Kane to work with the University of Miami to study DispersinB® Acne Cleanser in mild to moderate Acne VulgarisWINNIPEG, Manitoba,...
NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it...
Oral presentations will highlight the implementation of a validated research-use plasma pTau217 assay in the participant screening process for the...
Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10,...
SOUND+THERAPY is a bedside device that uses 40 Hertz gamma sound beats and light flashes to promote better sleep. Studies...
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation...